Brooks J R, Culebras J M
Am J Surg. 1976 Apr;131(4):516-20. doi: 10.1016/0002-9610(76)90167-7.
The choice of operation for ductal carcinoma of the pancreas is as yet not clear. Failure to make an early diagnosis still stands out as the major problem in the treatment of this disease and as a result the resectability rate is exceedingly low. Between 1964 and 1973, nineteen total pancreatectomies were performed at Peter Bent Brigham Hospital for all tumors of the pancreas. Sixteen of these were for ductal carcinoma. The mortality was 12.5 per cent. When total pancreatectomy is compared with the Whipple procedure and a simple bypass procedure and when the tumor disease encountered is corrected for stage of disease, it is apparent that total pancreatectomy carries a statistically significant longer survival for patients with Stages I and II disease (no lymph node involvement) than the other two procedures. For Stages III and IV, there is no difference in survival between the three different operations. We therefore conclude that total pancreatectomy carries a better survival prognosis than other procedures performed for Stage I and II ductal carcinoma of the pancreas.
目前,胰腺癌导管癌的手术选择仍不明确。未能早期诊断仍是这种疾病治疗中的主要问题,因此可切除率极低。1964年至1973年间,彼得·本特·布里格姆医院对所有胰腺肿瘤进行了19例全胰切除术。其中16例是针对导管癌的。死亡率为12.5%。当将全胰切除术与惠普尔手术和简单的旁路手术进行比较,并且对所遇到的肿瘤疾病进行疾病分期校正时,很明显,对于I期和II期疾病(无淋巴结受累)的患者,全胰切除术在统计学上具有显著更长的生存期,优于其他两种手术。对于III期和IV期,三种不同手术的生存期没有差异。因此,我们得出结论,对于I期和II期胰腺癌导管癌,全胰切除术的生存预后优于其他手术。